GSCC

TWELFTH Conference on CANCER THERAPY with ANTIBODIES & IMMUNOCONJUGATES, October 16-18, 2008.
Conference Information and Registration

Welcome to the web site for the Garden State Cancer Center at the Center for Molecular Medicine and Immunology. We are located at 520 Belleville Avenue in Belleville, NJ. This web site will keep you updated on our most current research and treatment efforts. The Center has focused on a biological approach to the diagnosis and treatment of cancer. This treatment modality involves the use of the body's own defense system, or substances produced by it, to combat cancer and other related diseases. Our cutting-edge research in this area has the potential to impact on all of us, our loved ones, and future generations.

Cancer remains the second leading cause of death in New Jersey, as well as in our nation. Indeed, over 41,000 New Jerseyans will be diagnosed with cancer this year. Celebrating the opening of the Garden State Cancer Center in its permanent home was truly a milestone in our development. We can now accelerate our research programs and expand our involvement in clinical research throughout the tri-state region.

On Monday, April 28, 2008 at The Hilton at Short Hills, the Gala of Hope took place, continuing the tradition of recognizing those who support the work of The Garden State Cancer Center (GSCC) through the GSCC Foundation, Inc. Governor Brendan T. Byrne emceed the evening, acknowledging:

Yogi Berra, Yankee Legend, Guest of Honor

Jos van der Woert, Vice-President Global Oncology, Schering-Plough, Honoree

Ann M. Limberg, President Bank of America New Jersey, Honorary Chair

We invite you to support the Center on our 25th Anniversary Year of visionary cancer research and treatment. Please contact Joe Milanowycz, Acting Director of the GSCC Foundation via email to jmilanowycz@gscancer.org

With new grants awarded by the National Institutes of Health and other health related organizations, our continued growth will provide new affiliations and more opportunities for patients to be placed on clinical trials, thereby offering biological therapy as an option to patients for whom traditional treatments have not been effective. Research holds many answers. With continued support, we will find those answers.

David M. Goldenberg, Sc.D., M.D.
President, Garden State Cancer Center and Center for Molecular Medicine and Immunology.